Some comments breaking
- Preliminary evidence suggests latest coronavirus variant carries higher risk of reinfection than other variants of concern
- It may have a 'growth' advantage
But the main issues remains - is the vaccine effective against it?
WHO raises preliminary study issue which may hit risk into close
Top Brokers
Sponsored
investingLive is a market news and analysis platform that lists and reviews forex brokers for informational use only. We do not provide investment advice or brokerage services. CFDs are complex, high-risk products and may not be suitable for all investors. investingLive is not responsible for any trading losses or decisions made based on content found on our site.
